Budesonide–glycopyrronium–formoterol fumarate dihydrate in uncontrolled asthma (KALOS and LOGOS): twin multicentre, double-blind, double-dummy, parallel-group, randomised, phase 3 trials
1. 请及时下载文件确认是否正确, 系统将在 2026-03-23 09:47:26 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/s2213-2600(25)00457-6
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2213260025004576
其他信息:
出版社: Elsevier BV
作者: Alberto Papi; Robert A Wise; David J Jackson; Njira Lugogo; Ruchong Chen; Teodora Trasieva; Chidi Obasi; Charlotta Movitz; Jesse Helman; Patricia Salter; Katarzyna Springer; Marco Bondoc; Mihir Shah; Katharine Knappenberger; Karin Bowen; Hitesh Pandya; Ayman Megally; Mehul Patel

